The impact of the EVLP on the lung microbiome and its inflammatory reaction
- PMID: 39588198
- PMCID: PMC11587763
- DOI: 10.3389/ti.2024.12979
The impact of the EVLP on the lung microbiome and its inflammatory reaction
Abstract
The pulmonary microbiome has emerged as a significant factor in respiratory health and diseases. Despite the sterile conditions maintained during ex vivo lung perfusion (EVLP), the use of antibiotics in the perfuse liquid can lead to dynamic changes in the lung microbiome. Here, we present the design of a study that aims to investigate the hypothesis that EVLP alters the lung microbiome and induces tissue inflammation. This pilot, prospective, controlled study will be conducted in two Spanish donor centers and will include seven organ donors after brain death or after controlled cardiac death. After standardized retrieval, the left lung will be preserved in cold storage and the right lung will be perfused with EVLP. Samples from bronchoalveolar lavage, perfusion and preservation solutions, and lung biopsies will be collected from both lungs and changes in lung microbiome and inflammatory response will be compared.
Keywords: EVLP; ex vivo lung perfusion; inflammatory response; lung donor; lung microbiome; primary graft dysfunction; protocol study.
Copyright © 2024 Grando, Boada, Faner, Gómez-Ollés, Ruiz, Bohils, Albiol, Marrero, Rosell, Salinas, Ruiz, Ruiz, Rodríguez-Villar, Ureña, Paredes-Zapata, Guirao, Sánchez-Etayo, Molins, Quiroga, Gómez-Brey, Michavila, Sandiumenge, Agustí, Ramos and Bello.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes D, Jr, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Eighth Adult Lung Transplantation Report — 2021; Focus on Recipient Characteristics. J Heart Lung Transplant (2021) 40:1060–72. 10.1016/j.healun.2021.07.021 - DOI - PMC - PubMed
-
- Snell GI, Yusen RD, Weill D, Strueber M, Garrity E, Reed A, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, Part I: Definition and Grading—A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2017) 36:1097–103. 10.1016/j.healun.2017.07.021 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
